5 drug(s) with this reaction
1,044 total reports
Loss Of Consciousness has been reported as an adverse reaction across 5 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,044 adverse event reports mention loss of consciousness in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with loss of consciousness, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have loss of consciousness listed in their FDA adverse event reports, sorted by report count:
In addition to loss of consciousness, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
5 drug(s) manufactured by Chattem Inc have loss of consciousness listed in their FDA adverse event reports: LIDOCAINE, MENTHOL, LEVOCETIRIZINE DIHYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, LIDOCAINE HCL, CAMPHOR, MENTHOL.
There are a combined 1,044 reports of loss of consciousness across 5 Chattem Inc drug(s) in the FDA adverse event database.